about
The genetics of bipolar disorder: genome ‘hot regions,’ genes, new potential candidates and future directionsAntidepressants and Body WeightGenetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathwaysNeural network analysis in pharmacogenetics of mood disordersInfluence of postpartum onset on the course of mood disorders.From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatmentFamily-based association study of 5-HTTLPR, TPH, MAO-A, and DRD4 polymorphisms in mood disordersPharmacogenetics of lithium prophylaxis in mood disorders: analysis of COMT, MAO-A, and Gbeta3 variantsHTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studiesClozapine resistance: augmentation strategiesImprovement of cognitive functioning in mood disorder patients with depressive symptomatic recovery during treatment: an exploratory analysisAre mindfulness-based interventions effective for substance use disorders? A systematic review of the evidenceDoes mindfulness training improve cognitive abilities? A systematic review of neuropsychological findingsHSP70 polymorphisms in first psychotic episode drug-naïve schizophrenic patientsProgress and prospects in pharmacogenetics of antidepressant drugs.No association of a set of candidate genes on haloperidol side effects.The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disordersMetabolic risk factor profile associated with use of second generation antipsychotics: a cross sectional study in a Community Mental Health CentreThe atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials.Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients.Dopamine receptor D2 and D4 genes, GABA(A) alpha-1 subunit genes and response to lithium prophylaxis in mood disorders.Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics.Possible influence of CREB1, CREBBP and CREM variants on diagnosis and treatment outcome in patients with schizophrenia.Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder.Mindfulness based cognitive therapy for psychiatric disorders: a systematic review and meta-analysis.Pharmacogenetics of antidepressant response.Serotonin transporter 5HTTLPR polymorphism and affective disorders: no evidence of association in a large European multicenter study.The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings.Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.5-HT 1A polymorphism and self-transcendence in mood disorders.Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: a systematic review and meta-analysis.Abelson helper integration site-1 gene variants on major depressive disorder and bipolar disorderThe 5-HT2C receptor as a target for mood disorders.Pharmacogenetics in affective disorders.ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.Lithium long-term treatment in mood disorders: clinical and genetic predictors.5-HT2A SNPs and the Temperament and Character Inventory.5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies.Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants.
P50
Q22251105-EDB52B92-58B8-40A3-81A0-FB3DDA63421FQ22305456-B3B77E4A-79BB-48B8-9278-CF19639490A4Q24629875-4BC3636A-E9F9-4E3A-A044-00C85E4EF646Q24792166-F8894E44-0B1F-4CC5-B2C8-BC58EE369206Q25256727-58DF41AC-D108-4589-A05C-F8360E437569Q27015830-069CA4FC-49ED-4259-850D-F5CAD4F2EEDAQ28216637-B6883601-C5B9-428C-BE8F-9F458B320F5DQ28216643-2D7BA0D7-6AFE-43D8-B953-DD16BDF1D602Q28240283-45BAFDEE-436B-49B1-A0F8-253DD94D1E31Q28247668-3FFE48A5-E167-468E-8B51-D4FC32A58BE7Q28262333-2868CE81-6287-48E8-903B-1EE233E55DF4Q28286632-3774F9DC-FB39-4A1C-A85E-FDBEC4BCF51FQ28301759-D2091AB4-7F0C-4949-9797-4842D83910ADQ28307786-41D35CA2-5892-4710-A75C-4AFB5053BAD1Q30249569-BA8FBCD6-435F-4DE0-B6E7-DD19AA171DD0Q30424511-3CFEB70F-14C3-4EAF-95FA-29D65EFF3753Q30583384-B2BFDA7E-96DD-4855-A48F-BB9449EC23FAQ33236751-03A6151D-0D06-46C9-A86C-F6298A5A011CQ33311120-E4710AA1-BD2D-46FB-8E20-51428061AAC7Q33572001-D4F4B8B1-4136-4E8F-AF91-248757460CEEQ33876177-402E1892-E70B-4C74-A9A4-74A4F2B2A8FEQ34017507-56B0B140-FF41-47D8-939A-A541BADE13D5Q34025151-0DBC0717-2DD3-45D2-95FF-70443CA82D2DQ34029993-AA47EA22-21E1-4D57-A29B-B08A7F4AF987Q34030962-5DBADFB8-CF38-40F9-8AFD-D9EAFB4576D6Q34138406-07F23C34-A093-4C6F-BA7F-35319B57C47FQ34155796-DAEB98B2-FA82-4BAA-9BF5-59E6C7CEC87AQ34291371-E6AC3D24-0A6D-404C-811A-F13B5A6C45CCQ34354633-67EA673C-BD29-43B9-816A-55FC138033BCQ34424865-9E3F9E0B-9A4D-4633-A958-61E6B32AE468Q34425984-8722DD18-0272-405B-92AD-8A1B3492A590Q34470723-87760760-8958-4833-BD2D-209E3B0F0ABCQ34476520-E102D1CC-1F5A-40D6-9082-2CB19786B855Q34546030-14538867-82D7-448F-82F8-FCCF8A1037FEQ34574406-6A75710C-9CD5-4558-9A8B-2F0CF2A09C8AQ34583477-4049015A-08B6-43C3-B24E-4D2C4F8F8DE5Q34609171-206783D7-B09F-4D7E-8A57-B908D1EF922BQ34641532-995E8297-DCA6-4F12-B9F4-CD3F26FBE3A8Q34719766-05E7358A-E073-44EB-BB3D-F6385ED30F6DQ34985957-8AD0579F-2CA6-4FB5-8BD8-16A212014D8E
P50
description
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Alessandro Serretti
@ast
Alessandro Serretti
@en
Alessandro Serretti
@es
Alessandro Serretti
@nl
Alessandro Serretti
@sl
type
label
Alessandro Serretti
@ast
Alessandro Serretti
@en
Alessandro Serretti
@es
Alessandro Serretti
@nl
Alessandro Serretti
@sl
altLabel
alessandro serretti
@en
prefLabel
Alessandro Serretti
@ast
Alessandro Serretti
@en
Alessandro Serretti
@es
Alessandro Serretti
@nl
Alessandro Serretti
@sl
P1053
G-3955-2017
P106
P1153
55141874600
P21
P214
46150868217822071111
P31
P496
0000-0003-4363-3759
P735
P7859
lccn-n2016183653